Log in to save to my catalogue

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b92fb27767c475693a3d55f22417df7

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

About this item

Full title

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

Publisher

Cham: Springer International Publishing

Journal title

EJNMMI Radiopharmacy and Chemistry, 2024-02, Vol.9 (1), p.14-14, Article 14

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Programmed cell death ligand 1 (PD-L1) plays a critical role in the tumor microenvironment and overexpression in several solid cancers has been reported. This was associated with a downregulation of the local immune response, specifically of T-cells. Immune checkpoint inhibitors showed a potential to break this localized immune paraly...

Alternative Titles

Full title

Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6b92fb27767c475693a3d55f22417df7

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b92fb27767c475693a3d55f22417df7

Other Identifiers

ISSN

2365-421X

E-ISSN

2365-421X

DOI

10.1186/s41181-024-00243-5

How to access this item